Download video

#LWKC Webinar - Advancements in Metastatic Kidney Cancer with Professor Thomas Powles

922 views

Kidney Cancer UK

3 years ago

#LWKC Webinar - Advancements in Metastatic Kidney Cancer with Professor Thomas Powles

#LWKC Webinar - Advancements in Metastatic Kidney Cancer with Professor Thomas Powles

#LWKC Webinar - Advancements in Metastatic Kidney Cancer with Professor Thomas Powles
1:27:40
#LWKC Webinar - Advancements in Metastatic Kidney Cancer with Professor Thomas Powles
by Kidney Cancer UK
Kidney Cancer UK #LWKC Webinar - Clinical Trials in Available in the UK
44:12
Kidney Cancer UK #LWKC Webinar - Clinical Trials in Available in the UK
by Kidney Cancer UK
Kidney Cancer UK - #LWKC Webinar; 'Metastatic treatments in the UK'
1:04:51
Kidney Cancer UK - #LWKC Webinar; 'Metastatic treatments in the UK'
by Kidney Cancer UK
#LWCK Webinar - Clinical Trials Update (Autumn 2021)
46:52
#LWCK Webinar - Clinical Trials Update (Autumn 2021)
by Kidney Cancer UK
Professor Dr.Thomas Powles - Kidney Cancer Symptoms
3:59
Professor Dr.Thomas Powles - Kidney Cancer Symptoms
by Kidney Cancer UK
Thomas Powles on The Uromigos: Live \& Unplugged Bladder Cancer Session
1:46
Thomas Powles on The Uromigos: Live \& Unplugged Bladder Cancer Session
by GU Oncology Now
Thomas Powles, MD, PhD, FCRP, regarding the EV-301 Phase III clinical study from ASCO GU 2021
2:40
Thomas Powles, MD, PhD, FCRP, regarding the EV-301 Phase III clinical study from ASCO GU 2021
by OBRoncology
Living with kidney cancer Webinars - Second line treatment for metastatic disease
41:25
Living with kidney cancer Webinars - Second line treatment for metastatic disease
by Kidney Cancer UK
Detection of Bone Disease Thomas Powles, M.D.
9:47
Detection of Bone Disease Thomas Powles, M.D.
by Kidney Cancer
Alan McLoughlin My Kidney Cancer Journey Parts 1 \& 2
6:14
Alan McLoughlin My Kidney Cancer Journey Parts 1 \& 2
by Kidney Cancer UK
Alan Mcloughlin - My Kidney Cancer Journey Part 4
13:14
Alan Mcloughlin - My Kidney Cancer Journey Part 4
by Kidney Cancer UK
Hollyann Prince - Living with the consequences of a kidney cancer misdiagnosis
12:16
Hollyann Prince - Living with the consequences of a kidney cancer misdiagnosis
by Kidney Cancer UK
Kidney Cancer UK #LWKC Webinar - Surgery \& Recovery Process
55:54
Kidney Cancer UK #LWKC Webinar - Surgery \& Recovery Process
by Kidney Cancer UK
How do we select the urothelial carcinoma patients who will benefit from checkpoint inhibitors?
0:57
How do we select the urothelial carcinoma patients who will benefit from checkpoint inhibitors?
by VJOncology
Thomas Powles, MD, PhD, FCRP, offers opinion on whether the results of EV-301 are practice-changing
1:34
Thomas Powles, MD, PhD, FCRP, offers opinion on whether the results of EV-301 are practice-changing
by OBRoncology
Promising early results for cetrelimab plus erdafitinib reported for advanced UC | Thomas Powles
2:23
Promising early results for cetrelimab plus erdafitinib reported for advanced UC | Thomas Powles
by Medicine Matters oncology
What's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
4:11
What's next for checkpoint inhibitors in metastatic urothelial bladder cancer?
by VJOncology
Prof.Yu and Prof.Thomas Powles: the phase 3 trial of First Line Maintenance Immunotherapy
24:39
Prof.Yu and Prof.Thomas Powles: the phase 3 trial of First Line Maintenance Immunotherapy
by Oncology Frontier
Aiming for Long Term Success in Kidney Cancer Treatment
1:09
Aiming for Long Term Success in Kidney Cancer Treatment
by curetoday
Dr. Powles on the Mission of the Uromigos Twitter Group
1:06
Dr. Powles on the Mission of the Uromigos Twitter Group
by OncLive
Thomas Powles, MD, MBBS, MRCP, regarding immunotherapy \& chemotherapy combinations in bladder cancer
2:17
Thomas Powles, MD, MBBS, MRCP, regarding immunotherapy \& chemotherapy combinations in bladder cancer
by OBRoncology
Dr. Powles on FDA Approval of Pembrolizumab Plus Axitinib in Advanced RCC
1:40
Dr. Powles on FDA Approval of Pembrolizumab Plus Axitinib in Advanced RCC
by OncLive
NORSE: erdafitinib + cetrelimab in mUC with FGFR alterations
3:42
NORSE: erdafitinib + cetrelimab in mUC with FGFR alterations
by VJOncology